# Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia

> **NCT07537413** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 430 (estimated)

## Conditions studied

- Community Acquired Pneumonia (CAP)

## Interventions

- **DRUG:** Ceftriaxone 1 gram daily
- **DRUG:** Ceftriaxone 2 grams daily

## Key facts

- **NCT ID:** NCT07537413
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-02-28
- **Target enrollment:** 430 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537413, "Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07537413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*